Skip to content
★ Sign in to follow
CK

Chee Kong Choo

Executive
CytoMed Therapeutics Ltd
Insider activity · 24 months5 buys0 salesCumulative net flow
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€636k
▼ Sales (0 ops.)
—

Latest filing published 24 Jul 2026 for CytoMed Therapeutics Ltd, €132k.

Filing timeline

BuySale
Chee Kong Choo

Insider track record

Disclosed buys
5
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Chee Kong Choo: trading record in brief

Chee Kong Choo appears in our data through filings on CytoMed Therapeutics Ltd shares, published by SEC (Form 4). Over a trading history stretching from 13 May 2026 to 20 July 2026, the count stands at 5 filings.

No open-market sale appears; the market trades are 5 purchases worth €636k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €131k. Relative to company size, the median is 1.4% of market cap (4 purchases with a known value).

The latest filing, published on 24 July 2026, reports an open-market purchase of €131k in CytoMed Therapeutics Ltd. The median gap between a trade and its publication by SEC (Form 4) is 10 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Chee Kong Choo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    DirectorExecutivesCytoMed Therapeutics Ltd
    150,000 USD0SEC
    100,000 shares@ US$1.50ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITEDSEC:0001493152-26-034516:0
    Canonical exit: 12 Oct 2026 (T+90)
  • ▲
    DirectorExecutivesCytoMed Therapeutics Ltd
    150,000 USD0SEC
    100,000 shares@ US$1.50ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITEDSEC:0001493152-26-034516:1
    Canonical exit: 18 Oct 2026 (T+90)
  • ▲
    DirectorExecutivesCytoMed Therapeutics Ltd
    150,000 USD0SEC
    100,000 shares@ US$1.50ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITEDSEC:0001493152-26-034654:0
    Canonical exit: 12 Oct 2026 (T+90)
  • ▲
    DirectorExecutivesCytoMed Therapeutics Ltd
    150,000 USD0SEC
    100,000 shares@ US$1.50ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITEDSEC:0001493152-26-034654:1
    Canonical exit: 18 Oct 2026 (T+90)
  • ▲
    DirectorExecutivesCytoMed Therapeutics Ltd
    128,778 USD23SEC
    112,000 shares@ US$1.1498100.0% of flowOrdinary Shares, no par value per shareSEC:0001493152-26-028589:0
    Canonical exit: 11 Aug 2026 (T+90)

5 of 5 declarations